TIRZEPATIDE ACT AS Dual GIP and GLP-1 receptor agonist. It improves satiety and caloric control, enhances glucose-dependent insulin release, reduces glucagon signaling when appropriate, and slows gastric emptying. THIS PRODUCT USED ONLY FOR RESEARCH USE